<html>
    <head>
        <meta charset="utf-8">
        
            <script src="lib/bindings/utils.js"></script>
            <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/dist/vis-network.min.css" integrity="sha512-WgxfT5LWjfszlPHXRmBWHkV2eceiWTOBvrKCNbdgDYTHrT2AeLCGbF4sZlZw3UMN3WtL0tGUoIAKsu8mllg/XA==" crossorigin="anonymous" referrerpolicy="no-referrer" />
            <script src="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/vis-network.min.js" integrity="sha512-LnvoEWDFrqGHlHmDD2101OrLcbsfkrzoSpvtSQtxK3RMnRV0eOkhhBN2dXHKRrUU8p2DGRTk35n4O8nWSVe1mQ==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>
            
        
<center>
<h1></h1>
</center>

<!-- <link rel="stylesheet" href="../node_modules/vis/dist/vis.min.css" type="text/css" />
<script type="text/javascript" src="../node_modules/vis/dist/vis.js"> </script>-->
        <link
          href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/css/bootstrap.min.css"
          rel="stylesheet"
          integrity="sha384-eOJMYsd53ii+scO/bJGFsiCZc+5NDVN2yr8+0RDqr0Ql0h+rP48ckxlpbzKgwra6"
          crossorigin="anonymous"
        />
        <script
          src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/js/bootstrap.bundle.min.js"
          integrity="sha384-JEW9xMcG8R+pH31jmWH6WWP0WintQrMb4s7ZOdauHnUtxwoG2vI5DkLtS3qm9Ekf"
          crossorigin="anonymous"
        ></script>


        <center>
          <h1></h1>
        </center>
        <style type="text/css">

             #mynetwork {
                 width: 100%;
                 height: 750px;
                 background-color: #ffffff;
                 border: 1px solid lightgray;
                 position: relative;
                 float: left;
             }

             

             
             #config {
                 float: left;
                 width: 400px;
                 height: 600px;
             }
             

             
        </style>
    </head>


    <body>
        <div class="card" style="width: 100%">
            
            
            <div id="mynetwork" class="card-body"></div>
        </div>

        
        
            <div id="config"></div>
        

        <script type="text/javascript">

              // initialize global variables.
              var edges;
              var nodes;
              var allNodes;
              var allEdges;
              var nodeColors;
              var originalNodes;
              var network;
              var container;
              var options, data;
              var filter = {
                  item : '',
                  property : '',
                  value : []
              };

              

              

              // This method is responsible for drawing the graph, returns the drawn network
              function drawGraph() {
                  var container = document.getElementById('mynetwork');

                  

                  // parsing and collecting nodes and edges from the python
                  nodes = new vis.DataSet([{"color": "#1f77b4", "id": "infection", "label": "infection", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.09.27.25336412"}, {"color": "#1f77b4", "id": "JN.1/KP.2", "label": "JN.1/KP.2", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.16.682893"}, {"color": "#aec7e8", "id": "S-induced", "label": "S-induced", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.16.682893"}, {"color": "#1f77b4", "id": "acute respiratory syndrome coronavirus 2", "label": "acute respiratory syndrome coronavirus 2", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.16.682699"}, {"color": "#1f77b4", "id": "RBD", "label": "RBD", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.16.682699"}, {"color": "#aec7e8", "id": "{Delta}3a7b-Nluc", "label": "{Delta}3a7b-Nluc", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.09.30.679586"}, {"color": "#aec7e8", "id": "ARM", "label": "ARM", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.16.682699"}, {"color": "#1f77b4", "id": "SARS-CoV-2 infection", "label": "SARS-CoV-2 infection", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.11.681833"}, {"color": "#1f77b4", "id": "inflammation", "label": "inflammation", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.13.682101"}, {"color": "#1f77b4", "id": "viral infection", "label": "viral infection", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.17.683096"}, {"color": "#aec7e8", "id": "AXiAEC", "label": "AXiAEC", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.17.683096"}, {"color": "#1f77b4", "id": "ALI", "label": "ALI", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.17.683096"}, {"color": "#1f77b4", "id": "SARS-CoV-2 infected", "label": "SARS-CoV-2 infected", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.17.683096"}, {"color": "#1f77b4", "id": "LOC SARS-CoV-2 infection", "label": "LOC SARS-CoV-2 infection", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.17.683096"}, {"color": "#aec7e8", "id": "dibasic", "label": "dibasic", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.16.682669"}, {"color": "#1f77b4", "id": "OC43", "label": "OC43", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.16.682669"}, {"color": "#1f77b4", "id": "viral infections", "label": "viral infections", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.16.682991"}, {"color": "#aec7e8", "id": "trametinib", "label": "trametinib", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.15.682635"}, {"color": "#aec7e8", "id": "sorafenib", "label": "sorafenib", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.15.682635"}, {"color": "#1f77b4", "id": "coronavirus infections", "label": "coronavirus infections", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.15.682635"}, {"color": "#aec7e8", "id": "Tyrosine", "label": "Tyrosine", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.17.683077"}, {"color": "#1f77b4", "id": "pan-coronaviruses infection", "label": "pan-coronaviruses infection", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.17.683077"}, {"color": "#1f77b4", "id": "HGS deficiency", "label": "HGS deficiency", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.17.683077"}, {"color": "#aec7e8", "id": "riboflavin tetrabutyrate", "label": "riboflavin tetrabutyrate", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.17.683077"}, {"color": "#aec7e8", "id": "RTB", "label": "RTB", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.17.683077"}, {"color": "#aec7e8", "id": "nucleic acid", "label": "nucleic acid", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.15.682549"}, {"color": "#1f77b4", "id": "weight loss", "label": "weight loss", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.13.682000"}, {"color": "#aec7e8", "id": "nilotinib", "label": "nilotinib", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.12.681938"}, {"color": "#aec7e8", "id": "tecovirimat", "label": "tecovirimat", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.12.681938"}, {"color": "#aec7e8", "id": "ST-246", "label": "ST-246", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.12.681938"}, {"color": "#aec7e8", "id": "urea", "label": "urea", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.11.681833"}, {"color": "#aec7e8", "id": "hydrogen bond donor", "label": "hydrogen bond donor", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.11.681833"}, {"color": "#aec7e8", "id": "once-daily", "label": "once-daily", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.11.681833"}, {"color": "#aec7e8", "id": "uridine", "label": "uridine", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.13.682008"}, {"color": "#1f77b4", "id": "ARCA", "label": "ARCA", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.13.682008"}, {"color": "#aec7e8", "id": "PASC", "label": "PASC", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.13.682101"}, {"color": "#1f77b4", "id": "infected with SARS-CoV-2 and viral", "label": "infected with SARS-CoV-2 and viral", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.13.682101"}, {"color": "#1f77b4", "id": "neurocognitive and behavioral impairments", "label": "neurocognitive and behavioral impairments", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.13.682101"}, {"color": "#1f77b4", "id": "neuroinflammation", "label": "neuroinflammation", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.13.682101"}, {"color": "#1f77b4", "id": "chronic disease", "label": "chronic disease", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.13.682101"}, {"color": "#1f77b4", "id": "respiratory disease", "label": "respiratory disease", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.09.681417"}, {"color": "#1f77b4", "id": "COVID-19 disease", "label": "COVID-19 disease", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.13.682000"}, {"color": "#aec7e8", "id": "anti-CD44", "label": "anti-CD44", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.13.682000"}, {"color": "#1f77b4", "id": "pulmonary infection", "label": "pulmonary infection", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.13.682000"}, {"color": "#1f77b4", "id": "mucormycosis", "label": "mucormycosis", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.13.681985"}, {"color": "#1f77b4", "id": "diabetes", "label": "diabetes", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.13.681985"}, {"color": "#aec7e8", "id": "zinc", "label": "zinc", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.13.681985"}, {"color": "#1f77b4", "id": "Rhizopus arrhizus", "label": "Rhizopus arrhizus", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.13.681985"}, {"color": "#aec7e8", "id": "hydrogen peroxide", "label": "hydrogen peroxide", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.13.681985"}, {"color": "#aec7e8", "id": "sodium chloride", "label": "sodium chloride", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.13.681985"}, {"color": "#aec7e8", "id": "amphotericin B", "label": "amphotericin B", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.13.681985"}, {"color": "#aec7e8", "id": "posaconazole", "label": "posaconazole", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.13.681985"}, {"color": "#aec7e8", "id": "ergosterol", "label": "ergosterol", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.13.681985"}, {"color": "#aec7e8", "id": "chitosan", "label": "chitosan", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.13.681985"}, {"color": "#aec7e8", "id": "iron", "label": "iron", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.13.681985"}, {"color": "#1f77b4", "id": "Candida albicans", "label": "Candida albicans", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.13.681985"}, {"color": "#1f77b4", "id": "fungal infection", "label": "fungal infection", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.13.681985"}, {"color": "#1f77b4", "id": "coronavirus infection", "label": "coronavirus infection", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.09.680815"}, {"color": "#aec7e8", "id": "ATAC", "label": "ATAC", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.09.681330"}, {"color": "#1f77b4", "id": "Respiratory infectious diseases", "label": "Respiratory infectious diseases", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.09.681417"}, {"color": "#1f77b4", "id": "upper respiratory tract", "label": "upper respiratory tract", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.09.681417"}, {"color": "#aec7e8", "id": "Ankara-(MVA)-SARS-2-ST", "label": "Ankara-(MVA)-SARS-2-ST", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.07.25337492"}, {"color": "#aec7e8", "id": "140", "label": "140", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.07.25337492"}, {"color": "#aec7e8", "id": "methacholine", "label": "methacholine", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.07.25337492"}, {"color": "#1f77b4", "id": "cough", "label": "cough", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.07.25337492"}, {"color": "#1f77b4", "id": "headache", "label": "headache", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.07.25337492"}, {"color": "#1f77b4", "id": "fatigue", "label": "fatigue", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.07.25337492"}, {"color": "#1f77b4", "id": "cancer", "label": "cancer", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.07.25337497"}, {"color": "#1f77b4", "id": "HPV-associated cancer", "label": "HPV-associated cancer", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.07.25337497"}, {"color": "#1f77b4", "id": "ResultsOverall", "label": "ResultsOverall", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.07.25337497"}, {"color": "#1f77b4", "id": "PD", "label": "PD", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.07.25337449"}, {"color": "#1f77b4", "id": "nirmatrelvir, and molnupiravir", "label": "nirmatrelvir, and molnupiravir", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.07.25337449"}, {"color": "#1f77b4", "id": "toxicities", "label": "toxicities", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.07.25337449"}, {"color": "#aec7e8", "id": "PK", "label": "PK", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.07.25337449"}, {"color": "#1f77b4", "id": "Respiratory Syndrome", "label": "Respiratory Syndrome", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.09.27.25336412"}, {"color": "#1f77b4", "id": "coronavirus disease 2019", "label": "coronavirus disease 2019", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.09.30.679586"}, {"color": "#1f77b4", "id": "nirmatrelvir or remdesivir, suggesting the feasibility of treating", "label": "nirmatrelvir or remdesivir, suggesting the feasibility of treating", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.09.30.679586"}, {"color": "#1f77b4", "id": "infections", "label": "infections", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.09.30.679586"}, {"color": "#1f77b4", "id": "nirmatrelvir) and RdRp (remdesivir) inhibitors.", "label": "nirmatrelvir) and RdRp (remdesivir) inhibitors.", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.09.30.679586"}, {"color": "#1f77b4", "id": "COVID-19 disease activity", "label": "COVID-19 disease activity", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.05.25337392"}, {"color": "#aec7e8", "id": "LTLAs", "label": "LTLAs", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.05.25337392"}, {"color": "#1f77b4", "id": "infectious diseases", "label": "infectious diseases", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.05.25337392"}, {"color": "#1f77b4", "id": "nontuberculous mycobacterial", "label": "nontuberculous mycobacterial", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.02.25337223"}, {"color": "#aec7e8", "id": "NTM", "label": "NTM", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.02.25337223"}, {"color": "#1f77b4", "id": "NTM-associated diseases", "label": "NTM-associated diseases", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.02.25337223"}, {"color": "#aec7e8", "id": "Mycobacterium avium", "label": "Mycobacterium avium", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.02.25337223"}, {"color": "#1f77b4", "id": "avium", "label": "avium", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.02.25337223"}, {"color": "#1f77b4", "id": "terrae", "label": "terrae", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.02.25337223"}, {"color": "#1f77b4", "id": "CoVs", "label": "CoVs", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.10.03.680419"}, {"color": "#aec7e8", "id": "nucleotide", "label": "nucleotide", "shape": "dot", "title": "Type: CHEMICAL\nDOI: 10.1101/2025.10.03.680419"}, {"color": "#1f77b4", "id": "SARS", "label": "SARS", "shape": "dot", "title": "Type: DISEASE\nDOI: 10.1101/2025.09.27.25336412"}]);
                  edges = new vis.DataSet([{"arrows": "to", "color": "gray", "from": "infection", "label": "LABEL_1", "title": "Sentence: The most severe manifestation of COVID-19 is observed in the distal lung, where SARS-CoV-2 infection can result in massive inflammation and barrier breakdown.\nDOI: 10.1101/2025.10.17.683096", "to": "inflammation", "width": 2}, {"arrows": "to", "color": "gray", "from": "infection", "label": "LABEL_1", "title": "Sentence: Following recovery from infection, female mice exhibited persistent neurocognitive and behavioral impairments, along with greater frequencies of inflammatory myeloid subsets, neuroinflammation, and dysregulated T cell subsets, including Tregs.\nDOI: 10.1101/2025.10.13.682101", "to": "neurocognitive and behavioral impairments", "width": 2}, {"arrows": "to", "color": "gray", "from": "infection", "label": "LABEL_1", "title": "Sentence: Following recovery from infection, female mice exhibited persistent neurocognitive and behavioral impairments, along with greater frequencies of inflammatory myeloid subsets, neuroinflammation, and dysregulated T cell subsets, including Tregs.\nDOI: 10.1101/2025.10.13.682101", "to": "neuroinflammation", "width": 2}, {"arrows": "to", "color": "gray", "from": "JN.1/KP.2", "label": "LABEL_1", "title": "Sentence: We found that administration of the JN.1/KP.2 booster elicited broadly neutralizing antibody responses against recently circulating SARS-CoV-2 variants that were accounted for by recall of Wu S-induced immunity.\nDOI: 10.1101/2025.10.16.682893", "to": "S-induced", "width": 2}, {"arrows": "to", "color": "gray", "from": "{Delta}3a7b-Nluc", "label": "LABEL_1", "title": "Sentence: Using a nanoluciferase (Nluc)-expressing attenuated recombinant SARS-CoV-2 lacking the open reading frames (ORF) 3a and 7b ({Delta}3a7b-Nluc), we characterized resistance profiles of two broadly protective NAbs targeting the S receptor binding domain (RBD) in S1 (1301B7) and the stem helix domain (SH) in S2 (1249A8).\nDOI: 10.1101/2025.10.16.682699", "to": "RBD", "width": 2}, {"arrows": "to", "color": "gray", "from": "ARM", "label": "LABEL_1", "title": "Sentence: In contrast, no ARM emerged under treatment with 1249A8, or an antibody cocktail of 1301B7 (RBD) + 1249A8 (SH).\nDOI: 10.1101/2025.10.16.682699", "to": "RBD", "width": 2}, {"arrows": "to", "color": "gray", "from": "SARS-CoV-2 infection", "label": "LABEL_1", "title": "Sentence: The most severe manifestation of COVID-19 is observed in the distal lung, where SARS-CoV-2 infection can result in massive inflammation and barrier breakdown.\nDOI: 10.1101/2025.10.17.683096", "to": "inflammation", "width": 2}, {"arrows": "to", "color": "gray", "from": "SARS-CoV-2 infection", "label": "LABEL_1", "title": "Sentence: The most severe manifestation of COVID-19 is observed in the distal lung, where SARS-CoV-2 infection can result in massive inflammation and barrier breakdown.\nDOI: 10.1101/2025.10.17.683096", "to": "infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "inflammation", "label": "LABEL_1", "title": "Sentence: Sex differences in inflammation and cognitive phenotypes during PASC were mediated by the presence of two X chromosomes.\nDOI: 10.1101/2025.10.13.682101", "to": "PASC", "width": 2}, {"arrows": "to", "color": "gray", "from": "inflammation", "label": "LABEL_1", "title": "Sentence: XX animals independent of chromosome Y presented with neuroinflammation and PASC along with infection-induced upregulation of the X-linked genes Xist and Tlr7 that regulate inflammation and chronic disease outcomes.\nDOI: 10.1101/2025.10.13.682101", "to": "chronic disease", "width": 2}, {"arrows": "to", "color": "gray", "from": "viral infection", "label": "LABEL_1", "title": "Sentence: Human-derived microphysiological systems pose a promising new class of in vitro models to study viral infection in a relevant context.\nDOI: 10.1101/2025.10.17.683096", "to": "infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "AXiAEC", "label": "LABEL_1", "title": "Sentence: Using an immortalized alveolar epithelial cell line, AXiAEC, and human lung microvascular endothelial cells (hLMVEC) we established a SARS-CoV-2 infection model on a LOC system.\nDOI: 10.1101/2025.10.17.683096", "to": "SARS-CoV-2 infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "AXiAEC", "label": "LABEL_1", "title": "Sentence: Using an immortalized alveolar epithelial cell line, AXiAEC, and human lung microvascular endothelial cells (hLMVEC) we established a SARS-CoV-2 infection model on a LOC system.\nDOI: 10.1101/2025.10.17.683096", "to": "infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "AXiAEC", "label": "LABEL_1", "title": "Sentence: Our results demonstrated that AXiAEC maturation at the air-liquid interface (ALI) is essential for SARS-CoV-2 infection.\nDOI: 10.1101/2025.10.17.683096", "to": "ALI", "width": 2}, {"arrows": "to", "color": "gray", "from": "ALI", "label": "LABEL_1", "title": "Sentence: Our results demonstrated that AXiAEC maturation at the air-liquid interface (ALI) is essential for SARS-CoV-2 infection.\nDOI: 10.1101/2025.10.17.683096", "to": "SARS-CoV-2 infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "ALI", "label": "LABEL_1", "title": "Sentence: Our results demonstrated that AXiAEC maturation at the air-liquid interface (ALI) is essential for SARS-CoV-2 infection.\nDOI: 10.1101/2025.10.17.683096", "to": "infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "LOC SARS-CoV-2 infection", "label": "LABEL_1", "title": "Sentence: Finally, we evaluated the application of the LOC SARS-CoV-2 infection model for efficacy testing and demonstrated the antiviral effect of remdesivir.\nDOI: 10.1101/2025.10.17.683096", "to": "SARS-CoV-2 infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "LOC SARS-CoV-2 infection", "label": "LABEL_1", "title": "Sentence: Finally, we evaluated the application of the LOC SARS-CoV-2 infection model for efficacy testing and demonstrated the antiviral effect of remdesivir.\nDOI: 10.1101/2025.10.17.683096", "to": "infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "trametinib", "label": "LABEL_1", "title": "Sentence: We identified four host-directed drugs, donepezil, dH-ergocristine, trametinib and sorafenib, that could potentially be repurposed to treat coronavirus infections.\nDOI: 10.1101/2025.10.15.682635", "to": "sorafenib", "width": 2}, {"arrows": "to", "color": "gray", "from": "trametinib", "label": "LABEL_1", "title": "Sentence: We identified four host-directed drugs, donepezil, dH-ergocristine, trametinib and sorafenib, that could potentially be repurposed to treat coronavirus infections.\nDOI: 10.1101/2025.10.15.682635", "to": "coronavirus infections", "width": 2}, {"arrows": "to", "color": "gray", "from": "sorafenib", "label": "LABEL_1", "title": "Sentence: We identified four host-directed drugs, donepezil, dH-ergocristine, trametinib and sorafenib, that could potentially be repurposed to treat coronavirus infections.\nDOI: 10.1101/2025.10.15.682635", "to": "coronavirus infections", "width": 2}, {"arrows": "to", "color": "gray", "from": "Tyrosine", "label": "LABEL_1", "title": "Sentence: Here, we performed a genome-wide CRISPRi screening to identify the host protein, Hepatocyte Growth Factor-Regulated Tyrosine Kinase Substrate (HGS), as essential for the pan-coronaviruses infection both in vitro and in vivo.\nDOI: 10.1101/2025.10.17.683077", "to": "pan-coronaviruses infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "riboflavin tetrabutyrate", "label": "LABEL_1", "title": "Sentence: Leveraging this interaction, we designed M-derived peptides and screened over 5,000 FDA-approved drugs, identifying riboflavin tetrabutyrate (RTB).\nDOI: 10.1101/2025.10.17.683077", "to": "RTB", "width": 2}, {"arrows": "to", "color": "gray", "from": "weight loss", "label": "LABEL_1", "title": "Sentence: Here, we report that in mice infected with a mouse-adapted strain of SARS-CoV-2, treatment with a combination of two anti-CD44 monoclonal antibodies confers a significant survival benefit and reduces weight loss and clinical score of the mice on Day 4 post infection.\nDOI: 10.1101/2025.10.13.682000", "to": "infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "nilotinib", "label": "LABEL_1", "title": "Sentence: One top-ranked drug nilotinib is experimentally shown to have a significant 69% of antiviral efficacy of the FDA-approved antiviral tecovirimat (TPOXX(R) or ST-246).\nDOI: 10.1101/2025.10.12.681938", "to": "tecovirimat", "width": 2}, {"arrows": "to", "color": "gray", "from": "nilotinib", "label": "LABEL_1", "title": "Sentence: One top-ranked drug nilotinib is experimentally shown to have a significant 69% of antiviral efficacy of the FDA-approved antiviral tecovirimat (TPOXX(R) or ST-246).\nDOI: 10.1101/2025.10.12.681938", "to": "ST-246", "width": 2}, {"arrows": "to", "color": "gray", "from": "tecovirimat", "label": "LABEL_1", "title": "Sentence: One top-ranked drug nilotinib is experimentally shown to have a significant 69% of antiviral efficacy of the FDA-approved antiviral tecovirimat (TPOXX(R) or ST-246).\nDOI: 10.1101/2025.10.12.681938", "to": "ST-246", "width": 2}, {"arrows": "to", "color": "gray", "from": "urea", "label": "LABEL_1", "title": "Sentence: Multiple strategies were pursued to overcome these issues, including replacing a urea function to reduce hydrogen bond donor count.\nDOI: 10.1101/2025.10.11.681833", "to": "hydrogen bond donor", "width": 2}, {"arrows": "to", "color": "gray", "from": "once-daily", "label": "LABEL_1", "title": "Sentence: Thus, AVI-6451 (4) is a potent Mac1 inhibitor lead with low intrinsic clearance, high oral bioavailability, and antiviral efficacy with once-daily oral administration in a mouse model of SARS-CoV-2 infection.\nDOI: 10.1101/2025.10.11.681833", "to": "SARS-CoV-2 infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "uridine", "label": "LABEL_1", "title": "Sentence: We examined different combinations of linear vectors: containing either N1-methylpseudouridines or uridine and capped with either ARCA (m7G(5\u0027)ppp(5\u0027)G) or CleanCap (m7G(5\u0027)ppp(5\u0027)m2G).\nDOI: 10.1101/2025.10.13.682008", "to": "ARCA", "width": 2}, {"arrows": "to", "color": "gray", "from": "PASC", "label": "LABEL_1", "title": "Sentence: While males are more likely to suffer severe outcomes during acute COVID-19, a greater proportion of females develop post-acute sequalae of COVID-19 (PASC) despite similar rates of infection.\nDOI: 10.1101/2025.10.13.682101", "to": "infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "PASC", "label": "LABEL_1", "title": "Sentence: To identify mechanisms of PASC, mice were infected with SARS-CoV-2 and viral, inflammatory, and behavioral outcomes were evaluated through 84 days post infection.\nDOI: 10.1101/2025.10.13.682101", "to": "infected with SARS-CoV-2 and viral", "width": 2}, {"arrows": "to", "color": "gray", "from": "PASC", "label": "LABEL_1", "title": "Sentence: XX animals independent of chromosome Y presented with neuroinflammation and PASC along with infection-induced upregulation of the X-linked genes Xist and Tlr7 that regulate inflammation and chronic disease outcomes.\nDOI: 10.1101/2025.10.13.682101", "to": "inflammation", "width": 2}, {"arrows": "to", "color": "gray", "from": "PASC", "label": "LABEL_1", "title": "Sentence: XX animals independent of chromosome Y presented with neuroinflammation and PASC along with infection-induced upregulation of the X-linked genes Xist and Tlr7 that regulate inflammation and chronic disease outcomes.\nDOI: 10.1101/2025.10.13.682101", "to": "chronic disease", "width": 2}, {"arrows": "to", "color": "gray", "from": "infected with SARS-CoV-2 and viral", "label": "LABEL_1", "title": "Sentence: To identify mechanisms of PASC, mice were infected with SARS-CoV-2 and viral, inflammatory, and behavioral outcomes were evaluated through 84 days post infection.\nDOI: 10.1101/2025.10.13.682101", "to": "infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "neurocognitive and behavioral impairments", "label": "LABEL_1", "title": "Sentence: Following recovery from infection, female mice exhibited persistent neurocognitive and behavioral impairments, along with greater frequencies of inflammatory myeloid subsets, neuroinflammation, and dysregulated T cell subsets, including Tregs.\nDOI: 10.1101/2025.10.13.682101", "to": "neuroinflammation", "width": 2}, {"arrows": "to", "color": "gray", "from": "neuroinflammation", "label": "LABEL_1", "title": "Sentence: XX animals independent of chromosome Y presented with neuroinflammation and PASC along with infection-induced upregulation of the X-linked genes Xist and Tlr7 that regulate inflammation and chronic disease outcomes.\nDOI: 10.1101/2025.10.13.682101", "to": "PASC", "width": 2}, {"arrows": "to", "color": "gray", "from": "neuroinflammation", "label": "LABEL_1", "title": "Sentence: XX animals independent of chromosome Y presented with neuroinflammation and PASC along with infection-induced upregulation of the X-linked genes Xist and Tlr7 that regulate inflammation and chronic disease outcomes.\nDOI: 10.1101/2025.10.13.682101", "to": "inflammation", "width": 2}, {"arrows": "to", "color": "gray", "from": "neuroinflammation", "label": "LABEL_1", "title": "Sentence: XX animals independent of chromosome Y presented with neuroinflammation and PASC along with infection-induced upregulation of the X-linked genes Xist and Tlr7 that regulate inflammation and chronic disease outcomes.\nDOI: 10.1101/2025.10.13.682101", "to": "chronic disease", "width": 2}, {"arrows": "to", "color": "gray", "from": "respiratory disease", "label": "LABEL_1", "title": "Sentence: However, vaccines against respiratory viruses predominantly have systemic administration routes that elicit strong responses in the circulation to prevent severe respiratory disease, but do not effectively block infection and onward community transmission.\nDOI: 10.1101/2025.10.09.681417", "to": "infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "anti-CD44", "label": "LABEL_1", "title": "Sentence: Here, we report that in mice infected with a mouse-adapted strain of SARS-CoV-2, treatment with a combination of two anti-CD44 monoclonal antibodies confers a significant survival benefit and reduces weight loss and clinical score of the mice on Day 4 post infection.\nDOI: 10.1101/2025.10.13.682000", "to": "infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "anti-CD44", "label": "LABEL_1", "title": "Sentence: Here, we report that in mice infected with a mouse-adapted strain of SARS-CoV-2, treatment with a combination of two anti-CD44 monoclonal antibodies confers a significant survival benefit and reduces weight loss and clinical score of the mice on Day 4 post infection.\nDOI: 10.1101/2025.10.13.682000", "to": "weight loss", "width": 2}, {"arrows": "to", "color": "gray", "from": "pulmonary infection", "label": "LABEL_1", "title": "Sentence: Our findings demonstrate that disruption of HA-receptor interactions is a way to prevent inflammatory pathology in pulmonary infection.\nDOI: 10.1101/2025.10.13.682000", "to": "infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "mucormycosis", "label": "LABEL_1", "title": "Sentence: During COVID-19 pandemic, the cases of mucormycosis increased substantially, with rhino-orbito-cerebral form linked to uncontrolled diabetes being the predominant manifestation.\nDOI: 10.1101/2025.10.13.681985", "to": "diabetes", "width": 2}, {"arrows": "to", "color": "gray", "from": "zinc", "label": "LABEL_1", "title": "Sentence: Some clinical and epidemiological studies associated the usage of zinc supplements with the occurrence of COVID-19 associated mucormycosis, but experimental evidence remains limited.\nDOI: 10.1101/2025.10.13.681985", "to": "mucormycosis", "width": 2}, {"arrows": "to", "color": "gray", "from": "zinc", "label": "LABEL_1", "title": "Sentence: This study aimed to elucidate the impact of zinc enrichment on Rhizopus arrhizus, the predominant causative agent of mucormycosis.\nDOI: 10.1101/2025.10.13.681985", "to": "Rhizopus arrhizus", "width": 2}, {"arrows": "to", "color": "gray", "from": "zinc", "label": "LABEL_1", "title": "Sentence: The effect of zinc supplementation (5 to 150 {micro}M) on fungal growth, metabolic activity, antifungal susceptibility and biofilm formation, along with cell-wall (Congo red), oxidative (hydrogen peroxide) and osmotic (sodium chloride) stress was evaluated in RPMI-1640.\nDOI: 10.1101/2025.10.13.681985", "to": "hydrogen peroxide", "width": 2}, {"arrows": "to", "color": "gray", "from": "zinc", "label": "LABEL_1", "title": "Sentence: The effect of zinc supplementation (5 to 150 {micro}M) on fungal growth, metabolic activity, antifungal susceptibility and biofilm formation, along with cell-wall (Congo red), oxidative (hydrogen peroxide) and osmotic (sodium chloride) stress was evaluated in RPMI-1640.\nDOI: 10.1101/2025.10.13.681985", "to": "sodium chloride", "width": 2}, {"arrows": "to", "color": "gray", "from": "zinc", "label": "LABEL_1", "title": "Sentence: The work demonstrates that zinc supplementation supports Rhizopus arrhizus growth, metabolism and stress response, and enhances the expression of key virulence factors, including mucoricin and iron transporters.\nDOI: 10.1101/2025.10.13.681985", "to": "iron", "width": 2}, {"arrows": "to", "color": "gray", "from": "Rhizopus arrhizus", "label": "LABEL_1", "title": "Sentence: This study aimed to elucidate the impact of zinc enrichment on Rhizopus arrhizus, the predominant causative agent of mucormycosis.\nDOI: 10.1101/2025.10.13.681985", "to": "mucormycosis", "width": 2}, {"arrows": "to", "color": "gray", "from": "Rhizopus arrhizus", "label": "LABEL_1", "title": "Sentence: The work demonstrates that zinc supplementation supports Rhizopus arrhizus growth, metabolism and stress response, and enhances the expression of key virulence factors, including mucoricin and iron transporters.\nDOI: 10.1101/2025.10.13.681985", "to": "iron", "width": 2}, {"arrows": "to", "color": "gray", "from": "hydrogen peroxide", "label": "LABEL_1", "title": "Sentence: The effect of zinc supplementation (5 to 150 {micro}M) on fungal growth, metabolic activity, antifungal susceptibility and biofilm formation, along with cell-wall (Congo red), oxidative (hydrogen peroxide) and osmotic (sodium chloride) stress was evaluated in RPMI-1640.\nDOI: 10.1101/2025.10.13.681985", "to": "sodium chloride", "width": 2}, {"arrows": "to", "color": "gray", "from": "amphotericin B", "label": "LABEL_1", "title": "Sentence: Susceptibility to amphotericin B and posaconazole was unchanged.\nDOI: 10.1101/2025.10.13.681985", "to": "posaconazole", "width": 2}, {"arrows": "to", "color": "gray", "from": "ergosterol", "label": "LABEL_1", "title": "Sentence: Zinc-supplemented cultures over-expressed multiple genes, notably those associated with respiratory electron transport chain, ergosterol biosynthesis, chitosan production, oxidative stress response, mucoricin, high-affinity iron permease, iron transport multi-copper oxidase and ferric-reductase-like protein.\nDOI: 10.1101/2025.10.13.681985", "to": "chitosan", "width": 2}, {"arrows": "to", "color": "gray", "from": "ergosterol", "label": "LABEL_1", "title": "Sentence: Zinc-supplemented cultures over-expressed multiple genes, notably those associated with respiratory electron transport chain, ergosterol biosynthesis, chitosan production, oxidative stress response, mucoricin, high-affinity iron permease, iron transport multi-copper oxidase and ferric-reductase-like protein.\nDOI: 10.1101/2025.10.13.681985", "to": "iron", "width": 2}, {"arrows": "to", "color": "gray", "from": "chitosan", "label": "LABEL_1", "title": "Sentence: Zinc-supplemented cultures over-expressed multiple genes, notably those associated with respiratory electron transport chain, ergosterol biosynthesis, chitosan production, oxidative stress response, mucoricin, high-affinity iron permease, iron transport multi-copper oxidase and ferric-reductase-like protein.\nDOI: 10.1101/2025.10.13.681985", "to": "iron", "width": 2}, {"arrows": "to", "color": "gray", "from": "coronavirus infection", "label": "LABEL_1", "title": "Sentence: Here, we report that coronavirus infection causes cytoplasmic poly(A)-binding protein (PABPC) activity to become limiting, which preferentially destabilizes short-tailed host mRNAs, occurring before the action of virally encoded mRNA-decay factor nsp1.\nDOI: 10.1101/2025.10.09.680815", "to": "infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "upper respiratory tract", "label": "LABEL_1", "title": "Sentence: The upper respiratory tract (URT) represents the primary access point for respiratory viruses, where initial host infection occurs.\nDOI: 10.1101/2025.10.09.681417", "to": "infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "cough", "label": "LABEL_1", "title": "Sentence: Over 28 days, mild or moderate adverse events occurred in 87% of participants, predominantly cough, headache, and fatigue, all resolved.\nDOI: 10.1101/2025.10.07.25337492", "to": "headache", "width": 2}, {"arrows": "to", "color": "gray", "from": "cough", "label": "LABEL_1", "title": "Sentence: Over 28 days, mild or moderate adverse events occurred in 87% of participants, predominantly cough, headache, and fatigue, all resolved.\nDOI: 10.1101/2025.10.07.25337492", "to": "fatigue", "width": 2}, {"arrows": "to", "color": "gray", "from": "headache", "label": "LABEL_1", "title": "Sentence: Over 28 days, mild or moderate adverse events occurred in 87% of participants, predominantly cough, headache, and fatigue, all resolved.\nDOI: 10.1101/2025.10.07.25337492", "to": "fatigue", "width": 2}, {"arrows": "to", "color": "gray", "from": "HPV-associated cancer", "label": "LABEL_1", "title": "Sentence: Focusing on Iowa, a state with the fastest rising incidence of HPV-associated cancer, we evaluated if county-level COVID-19 vaccination rates corresponded to county-level changes in rural-urban HPV vaccination completion trends.\nDOI: 10.1101/2025.10.07.25337497", "to": "cancer", "width": 2}, {"arrows": "to", "color": "gray", "from": "PK", "label": "LABEL_1", "title": "Sentence: Participants were monitored for 43 weeks to evaluate safety, pharmacokinetics (PK), and pharmacodynamics (PD; serum live virus neutralization).\nDOI: 10.1101/2025.10.07.25337449", "to": "PD", "width": 2}, {"arrows": "to", "color": "gray", "from": "Respiratory Syndrome", "label": "LABEL_1", "title": "Sentence: Ensitrelvir is an antiviral drug that specifically targets the main protease (Mpro) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been approved for the treatment of coronavirus disease 2019 (COVID-19) due to the conservation of its target protein which is essential in the viral lifecycle.\nDOI: 10.1101/2025.09.30.679586", "to": "coronavirus disease 2019", "width": 2}, {"arrows": "to", "color": "gray", "from": "nirmatrelvir or remdesivir, suggesting the feasibility of treating", "label": "LABEL_1", "title": "Sentence: Positively, G23del in Mpro does not render SARS-CoV-2 resistant to nirmatrelvir or remdesivir, suggesting the feasibility of treating infections with SARS-CoV-2 containing G23del with these other approved antivirals.\nDOI: 10.1101/2025.09.30.679586", "to": "infections", "width": 2}, {"arrows": "to", "color": "gray", "from": "nontuberculous mycobacterial", "label": "LABEL_1", "title": "Sentence: BackgroundThe incidence of nontuberculous mycobacterial (NTM) diseases is increasing globally, with risk factors remaining poorly understood.\nDOI: 10.1101/2025.10.02.25337223", "to": "NTM", "width": 2}, {"arrows": "to", "color": "gray", "from": "NTM", "label": "LABEL_1", "title": "Sentence: COVID-19 may alter respiratory tract conditions affecting NTM colonization and infection patterns.\nDOI: 10.1101/2025.10.02.25337223", "to": "infection", "width": 2}, {"arrows": "to", "color": "gray", "from": "NTM", "label": "LABEL_1", "title": "Sentence: ObjectiveTo evaluate species diversity of NTM isolated from patients with NTM-associated diseases with and without a history of COVID-19.\nDOI: 10.1101/2025.10.02.25337223", "to": "NTM-associated diseases", "width": 2}, {"arrows": "to", "color": "gray", "from": "NTM", "label": "LABEL_1", "title": "Sentence: Conversely, rare NTM species showed increased prevalence in COVID-19+ patients: M. kansasii complex (0% vs 8.1%, p\u003c0.05), M. terrae complex (0% vs 3.3%, p\u003c0.05), M. simiae complex (0.5% vs 7.0%, p\u003c0.05), and unclassifiable species (2.6% vs 12.9%, p\u003c0.05).\nDOI: 10.1101/2025.10.02.25337223", "to": "terrae", "width": 2}, {"arrows": "to", "color": "gray", "from": "Mycobacterium avium", "label": "LABEL_1", "title": "Sentence: COVID-19 was associated with a significant 28% reduction in Mycobacterium avium complex (MAC) prevalence (94.8% vs 66.8%, p\u003c0.05), primarily due to decreased M. avium isolation (80.3% vs 52.0%, p\u003c0.05).\nDOI: 10.1101/2025.10.02.25337223", "to": "avium", "width": 2}]);

                  nodeColors = {};
                  allNodes = nodes.get({ returnType: "Object" });
                  for (nodeId in allNodes) {
                    nodeColors[nodeId] = allNodes[nodeId].color;
                  }
                  allEdges = edges.get({ returnType: "Object" });
                  // adding nodes and edges to the graph
                  data = {nodes: nodes, edges: edges};

                  var options = {
    "configure": {
        "enabled": true,
        "filter": [
            "physics"
        ]
    },
    "edges": {
        "color": {
            "inherit": true
        },
        "smooth": {
            "enabled": true,
            "type": "dynamic"
        }
    },
    "interaction": {
        "dragNodes": true,
        "hideEdgesOnDrag": false,
        "hideNodesOnDrag": false
    },
    "physics": {
        "enabled": true,
        "forceAtlas2Based": {
            "avoidOverlap": 0,
            "centralGravity": 0.01,
            "damping": 0.4,
            "gravitationalConstant": -50,
            "springConstant": 0.08,
            "springLength": 100
        },
        "solver": "forceAtlas2Based",
        "stabilization": {
            "enabled": true,
            "fit": true,
            "iterations": 1000,
            "onlyDynamicEdges": false,
            "updateInterval": 50
        }
    }
};

                  


                  
                  // if this network requires displaying the configure window,
                  // put it in its div
                  options.configure["container"] = document.getElementById("config");
                  

                  network = new vis.Network(container, data, options);

                  

                  

                  


                  

                  return network;

              }
              drawGraph();
        </script>
    </body>
</html>